<DOC>
	<DOCNO>NCT01185990</DOCNO>
	<brief_summary>The study design identify specific pattern brain functional activity associate chronic , moderate severe tinnitus use resting-state MEG scan . Robust pattern identify study use biomarker subsequent clinical evaluation experimental drug treatment tinnitus . This study conduct MEG scan approximately 30 75 subject tinnitus approximately 15 healthy control subject . MEG scan obtain subject follow screening , clinical tinnitus evaluation . A subset 6 subject tinnitus cohort invite undergo evoked auditory assessment extend MEG scan session identify cortical region respond auditory stimulus . These six subject also evaluate single structural MRI scan support high-resolution mapping localized cortical region . MEG data analyze identify pattern brain activity specifically associate presence tinnitus use standard approach Orasi Synchronous Neural Interaction™ ( SNI ) test . MEG scan result also evaluate identify specific pattern functional activity correlate measure tinnitus severity Iowa Tinnitus Handicap Scale . This study test hypothesis moderate severe tinnitus associate alter pattern brain functional activity measure brief , resting-state MEG scan . This hypothesis test compare resting-state MEG scan tinnitus patient healthy control subject collect study available Orasi 's exist MEG scan database .</brief_summary>
	<brief_title>Tinnitus Measured MEG Synchronous Neural Interaction™ Test : Template Development</brief_title>
	<detailed_description />
	<mesh_term>Tinnitus</mesh_term>
	<criteria>Subject 18 75 year age time screen . Subject understands study procedure agree participate study give write informed consent . Subject nonsmoker . Subject judge good health base medical history brief physical examination . Subject diagnosis chronic , moderate severe ( Tinnitus Handicap Inventory score range 38 76 , inclusive ) , unilateral tinnitus unknown etiology , participate study healthy control subject . Subject severe hearing impairment , external middle ear disease temporomandibular joint disorder . Subject diagnosis significant neurological condition include Alzheimer 's disease , Parkinson 's disease , vascular dementia , Lewy body dementia frontal temporal dementia , human immunodeficiency virus , multiple sclerosis , severe traumatic brain injury . Subject history primary psychotic disorder ( e.g . schizophrenia , schizoaffective disorder , delusional disorder ) bipolar disorder . Subject history seizure , epilepsy , stroke , peripheral neuropathy , head trauma persistent postconcussive symptom , ADHD , dyslexia clinically significant neurological disease cognitive impairment . Subject current episode major depressive disorder . Subject use antidepressant , anxiolytic , antipsychotic antiepileptic medication past 6 month . Subject recent ( within 2 year ) history alcohol substance abuse/dependence . Subject complete MRI within 2 week prior MEG scan . Subject metal brace pacemaker may interfere MEG scan . Subject unable complete MEG scan procedure . The investigator concern regard safe participation subject study , reason investigator considers subject inappropriate study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>